Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Records History now includes a new Revision: v3.7.0 and removes the previous Revision: v3.6.6, updating the history with the latest version label.SummaryDifference0.1%

- Check37 days agoChange DetectedThe record history adds a new revision entry (v3.6.6) and removes the previous revision (v3.6.5), signaling an update to the study record's documentation.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry 'Revision: v3.6.5' has been added to the study's Record History, indicating an updated version of the page.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.6.4 was added to the record history, and the previous revision v3.6.3 was removed. This updates the page's release history to reflect the latest version.SummaryDifference0.1%

- Check94 days agoChange DetectedThe study's history now includes a new revision entry (v3.6.3), indicating an update to the record after the previous revision. The older revision (v3.6.2) appears as part of the former history and is superseded by the new entry.SummaryDifference0.1%

- Check101 days agoChange DetectedRecord History now includes a new revision entry (v3.6.2) and removes the older v3.6.0 entry, updating the versioning history of the study record.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.